Smith & Nephew SNATS ROE 2006-2018 | SNN

Current and historical return on equity (ROE) values for Smith & Nephew SNATS (SNN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Smith & Nephew SNATS ROE for the three months ending June 30, 2018 was 0.00%.
Smith & Nephew SNATS ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-06-30 $0.00B $4.64B 0.00%
2017-12-31 $0.00B $4.64B 0.00%
2017-06-30 $0.00B $4.20B 0.00%
2016-12-31 $0.16B $3.96B 4.00%
2015-12-31 $0.26B $3.97B 6.52%
2015-06-30 $0.35B $4.05B 8.63%
2014-12-31 $0.50B $4.04B 12.20%
2014-09-30 $0.50B $4.02B 12.24%
2014-06-30 $0.52B $4.16B 12.81%
2014-03-31 $0.56B $4.22B 14.01%
2013-12-31 $0.56B $4.05B 14.07%
2013-09-30 $0.54B $3.91B 13.71%
2013-06-30 $0.55B $3.90B 14.26%
2013-03-31 $0.71B $3.95B 18.91%
2012-12-31 $0.73B $3.88B 20.06%
2012-09-30 $0.73B $3.64B 21.01%
2012-06-30 $0.73B $3.56B 21.91%
2012-03-31 $0.59B $3.45B 18.30%
2011-12-31 $0.58B $3.19B 18.80%
2011-09-30 $0.62B $3.06B 20.86%
2011-06-30 $0.63B $3.13B 22.06%
2011-03-31 $0.61B $3.00B 23.17%
2010-12-31 $0.62B $2.77B 25.14%
2010-09-30 $0.56B $2.48B 24.41%
2010-06-30 $0.55B $2.31B 25.31%
2010-03-31 $0.53B $2.23B 25.71%
2009-12-31 $0.47B $2.18B 24.28%
2009-09-30 $0.46B $2.01B 25.17%
2009-06-30 $0.41B $1.88B 22.95%
2009-03-31 $0.39B $1.71B 22.33%
2008-12-31 $0.38B $1.70B 21.17%
2008-09-30 $0.36B $1.77B 20.05%
2008-06-30 $0.30B $1.81B 16.36%
2008-03-31 $0.31B $1.81B 16.04%
2007-12-31 $0.32B $1.82B 15.73%
2007-09-30 $0.36B $1.91B 16.92%
2007-06-30 $0.44B $2.16B 20.33%
2007-03-31 $0.42B $2.16B 20.15%
2006-12-31 $0.75B $2.17B 36.93%
2006-09-30 $0.70B $2.07B 37.12%
2006-06-30 $0.67B $2.01B 38.78%
2006-03-31 $0.67B $1.89B 42.18%
2005-12-31 $0.34B $1.57B 23.26%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $16.589B $4.765B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.569B 18.92
Abbott Laboratories (ABT) United States $122.855B 24.89
Stryker (SYK) United States $63.182B 23.82
Boston Scientific (BSX) United States $49.097B 24.81
Baxter (BAX) United States $34.600B 22.34
Zimmer Biomet Holdings (ZBH) United States $22.421B 14.54
ResMed (RMD) United States $15.674B 29.89
Perrigo (PRGO) Ireland $8.142B 12.36
Bio-Rad Laboratories (BIO) United States $7.677B 49.09
Canopy Growth (CGC) Canada $7.290B 0.00
Hill-Rom Holdings (HRC) United States $6.241B 19.53
Aurora Cannabis (ACB) Canada $5.730B 30.26
Haemonetics (HAE) United States $5.332B 46.90
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.752B 26.48
Hutchison China MediTech (HCM) China $4.204B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.765B 0.00
Neogen (NEOG) United States $3.198B 48.43
Agios Pharmaceuticals (AGIO) United States $3.093B 0.00
NuVasive (NUVA) United States $2.886B 26.85
National Vision Holdings (EYE) United States $2.497B 48.30
NxStage Medical (NXTM) United States $1.925B 0.00
Quidel (QDEL) United States $1.917B 24.99
Phibro Animal Health (PAHC) United States $1.327B 18.78
Aphria (APHA) $1.306B 0.00
AtriCure (ATRC) United States $1.204B 0.00
Cardiovascular Systems (CSII) United States $0.991B 1428.00
VAREX IMAGING (VREX) United States $0.918B 18.37
PetIQ (PETQ) United States $0.886B 22.96
Meridian Bioscience (VIVO) United States $0.778B 24.80
Surmodics (SRDX) United States $0.766B 116.65
OraSure Technologies (OSUR) United States $0.752B 42.35
Cerus (CERS) United States $0.726B 0.00
MacroGenics (MGNX) United States $0.693B 0.00
Omeros (OMER) United States $0.687B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.655B 21.00
Lantheus Holdings (LNTH) United States $0.652B 20.17
NanoString Technologies (NSTG) United States $0.527B 0.00
LeMaitre Vascular (LMAT) United States $0.502B 24.65
Owens & Minor (OMI) United States $0.433B 4.90
Quanterix (QTRX) United States $0.433B 0.00
TG Therapeutics (TGTX) United States $0.414B 0.00
Insys Therapeutics (INSY) United States $0.385B 0.00
Evolus (EOLS) United States $0.375B 0.00
VAPOTHERM INC (VAPO) United States $0.350B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.90
Cytosorbents (CTSO) United States $0.295B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.243B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
BioLife Solutions (BLFS) United States $0.207B 279.25
Rockwell Medical (RMTI) United States $0.172B 0.00
Chimerix (CMRX) United States $0.167B 0.00
Fonar (FONR) United States $0.135B 6.77
Imprimis Pharmaceuticals (IMMY) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
United-Guardian (UG) United States $0.079B 16.53
Female Health (VERU) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.27
CAS Medical Systems (CASM) United States $0.055B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.052B 0.00
Neurotrope (NTRP) United States $0.043B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Senestech (SNES) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00